‹ ›
MYP_011768
Basic Information
LP-53
Antimicrobial
Antiviral
Antiviral ▸ Anti-HIV ▸ Anti-HIV-1
Antiviral ▸ Antiviral mechanism ▸ Viral fusion inhibition
not Standard
26 amino acids
-
contains X representing unresolved or non-standard residue
Sequence
YTSLIHSLIEESQNQQEKNEQELLEX
Physicochemical Analysis
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available

Not available: incomplete physicochemical profile.

Molecular Weight
Not available
Isoelectric Point (pI)
Not available
Net Charge (pH 7.0)
Not available
GRAVY Index
Not available
Boman Index
Not available
Instability Index
Not available
The radar chart requires all six dimensions. Available values are listed above; missing values are not plotted as zero.
Residue Composition
Amino Acid Composition
Chemical Descriptors
Structural Visualization
3D PDB MODEL
Readable PDBLast file check: 2026-11-18T17:23:42.578682+00:00. File readability does not guarantee 3D display.
Match index: Listed
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0006362 REVIEWED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
noncanonical or placeholder-residue peptide [Modified]
Acetylation
Amidation
The 'X' at position 26 is Lys-C16(palmitic acid)
Bio-Activity Profile
Antimicrobial Antiviral
HIV-1 JRCSF; TZM-bl cells
0.021352±0.001876 μM
IC50
RECORD: Rec_0041623 REVIEWED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
HR2 fusion-inhibitory peptide
32630
Structure & Mods
linear peptide [Linear]
noncanonical stereochemical modification [Modified]
Acetylation
Amidation
The 'X' at position 26 is Lys-C16(palmitic acid)
Bio-Activity Profile
Antiviral Anti-HIV-1 Fusion inhibition
HIV-1 JRCSF | TZM-bl cells
0.021352±0.001876 μM
IC50
Mammalian: 2.8 h; Yeast: 10 min; E. coli: 2 min
RECORD: Rec_0117767 REVIEWED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
noncanonical or placeholder-residue peptide [Modified]
Acetylation
Amidation
The 'X' at position 26 is Lys-C16(palmitic acid)
Bio-Activity Profile
Antimicrobial Antiviral
HIV-1 HXB2; TZM-bl cells
0.002949±0.0004 μM
IC50
RECORD: Rec_0173435 REVIEWED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
HR2 fusion-inhibitory peptide
32630
Structure & Mods
linear peptide [Linear]
noncanonical stereochemical modification [Modified]
Acetylation
Amidation
The 'X' at position 26 is Lys-C16(palmitic acid)
Bio-Activity Profile
Antiviral Anti-HIV-1 Fusion inhibition
HIV-1 NL4-3 | TZM-bl cells
0.009968±0.002224 μM
IC50
Mammalian: 2.8 h; Yeast: 10 min; E. coli: 2 min
RECORD: Rec_0188168 REVIEWED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
noncanonical or placeholder-residue peptide [Modified]
unspecified non-canonical residue at 26
Bio-Activity Profile
Antiviral
HIV-1 JRCSF
1 2 NEXT LAST
Showing 5 records · Page 1 of 2